Amgen Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
| Name | Last | Prev. | High | Low | Chg. % | Vol. | Time | Price | |
|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 57.58 | 57.58 | 60.68 | 56.72 | -2.60% | 22.57M | 57.58-2.60% | 12/10 | |
PFE Pfizer Inc | 28.40 | 28.40 | 28.50 | 28.28 | +0.42% | 18.56M | 28.40+0.42% | 12/10 | |
GSK GSK plc DRC | 46.92 | 46.92 | 47.09 | 46.31 | +0.90% | 10.35M | 46.92+0.90% | 12/10 | |
NVO Novo Nordisk A/S ADR | 38.58 | 38.58 | 38.85 | 38.26 | -0.16% | 8.72M | 38.58-0.16% | 12/10 | |
MRK Merck & Company Inc | 145.45 | 145.45 | 146.36 | 144.64 | -0.10% | 8.02M | 145.45-0.10% | 12/10 |
| Name | Price |
|---|---|
RDY Dr. Reddy’s Labs ADR | 12.82+0.34+2.72% |
PRGO Perrigo | 15.45+0.39+2.59% |
ABBV AbbVie | 281.12+4.65+1.68% |
PBH Prestige Consumer Healthcare | 49.00+0.77+1.60% |
RPRX Royalty Pharma | 57.78+0.85+1.49% |
| Name | Price |
|---|---|
BMY Bristol-Myers Squibb | 57.58-1.54-2.60% |
BHC Bausch Health | 5.93-0.11-1.82% |
ELAN Elanco Animal Health | 22.56-0.36-1.57% |
ALKS Alkermes Plc | 40.26-0.35-0.86% |
SNY Sanofi ADR | 39.74-0.33-0.82% |